Pablo Albasanz-García/LinkedIn
Jan 14, 2026, 11:26
Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mechanisms of anticancer treatment-induced arterial and venous thrombosis
This narrative review explores how cancer therapies trigger blood clots through coagulation activation, vascular damage, tumor cell death materials, and inflammation—crucial for developing better thrombosis prevention strategies.
Authors: Pablo Albasanz-García, Mark Ward, Lucy Norris
Check out this article.”
Article: Mechanisms of anticancer treatment-induced arterial and venous thrombosis
Authors: Pablo Albasanz-García, Mark P. Ward, Lucy A. Norris
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 20, 2026, 13:18Ekaterina Balaian: Submission Open for Special Issue on Hematologic Metabolism
-
Jul 20, 2026, 12:54Victor Emmanuel: Preventing Severe Maternal Complications Associated With Anemia
-
Jul 20, 2026, 12:33Ney Carter Borges: The Evolving Role of Aspirin in Coronary Artery Disease
-
Jul 20, 2026, 12:15Zain Khalpey: Why the Cause of Reduced Perfusion Matters
-
Jul 20, 2026, 11:53ISTH 2026 Showcases Landmark Research and Launches Women’s Health Hub
-
Jul 20, 2026, 10:40Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
-
Jul 20, 2026, 10:30Marc Blondon: What Are the Current Practices For VTE Prevention in Pregnancy Worldwide?
-
Jul 20, 2026, 10:11Zeyad Bady: Advancing Thrombosis Research on the International Stage at ISTH 2026
-
Jul 20, 2026, 09:41Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026